Research Peptides · Cat. 060-25
Octreotide
Supplied as 500 µg per unit. Purity ≥ 97%. Molecular weight 1016.59. Species: Other species. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 060-25 |
|---|---|
| Product type | Research Peptides |
| Peptide family | Other Research Peptides |
| Species | Other species |
| Unit size | 500 µg |
| Molecular weight | 1016.59 Da |
| Purity | ≥ 97% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 500 µg of NET peptide. |
| Solubility | Soluble in water |
| Disulfide Bridge | Disulfide bridge(s): Cys2-Cys7 Constitutive somatostatin receptor subtype 2 activity attenuates GH synthesis. Ben-shlomo A, Pichurin O, Khalafi R, et al. Endocrinology. 2013;154(7):2399-409. Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation. Ben-shlomo A, Pichurin O, Barshop NJ, et al. Mol Endocrinol. 2007;21(10):2565-78. Regulation of growth hormone and prolactin gene expression and secretion by chimeric somatostatin-dopamine molecules. Gruszka A, Ren SG, Dong J, Culler MD, Melmed S. Endocrinology. 2007;148(12):6107-14. Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion. Ben-shlomo A, Wawrowsky KA, Proekt I, et al. J Biol Chem. 2005;280(25):24011-21. Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. Murray RD, Kim K, Ren SG, Chelly M, Umehara Y, Melmed S. J Clin Invest. 2004;114(3):349-56. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target. Janovick JA, Maya-nunez G, Conn PM. J Clin Endocrinol Metab. 2002;87(7):3255-62. |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is Octreotide?
What purity is listed for 060-25?
How should Octreotide be stored?
What is the sequence of Octreotide?
What is the intended use of 060-25?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.